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ABSTRACT
Mycobacterium tuberculosis (MTb) is the causative
agent of pulmonary tuberculosis (TB). MTb colonizes
the human lung, often entering a non-replicating
state before progressing to life-threatening active
infections. Transcriptional reprogramming is essen-
tial for TB pathogenesis. In vitro, Cmr (a member of
the CRP/FNR super-family of transcription regula-
tors) bound at a single DNA site to act as a dual
regulator of cmr transcription and an activator of
the divergent rv1676 gene. Transcriptional profiling
and DNA-binding assays suggested that Cmr directly
represses dosR expression. The DosR regulon is
thought to be involved in establishing latent tubercu-
losis infections in response to hypoxia and nitric ox-
ide. Accordingly, DNA-binding by Cmr was severely
impaired by nitrosation. A cmr mutant was better able
to survive a nitrosative stress challenge but was at-
tenuated in a mouse aerosol infection model. The
complemented mutant exhibited a ∼2-fold increase
in cmr expression, which led to increased sensitivity
to nitrosative stress. This, and the inability to restore
wild-type behaviour in the infection model, suggests
that precise regulation of the cmr locus, which is
associated with Region of Difference 150 in hyper-
virulent Beijing strains of Mtb, is important for TB
pathogenesis.
INTRODUCTION
Members of the cyclic AMP receptor (CRP)/fumarate ni-
trate reduction regulator (FNR) super-family of global
transcription regulators control a diverse range of bacte-
rial physiological functions. For example, different proteins
in this family control aspects of carbon, nitrogen and sul-
fur metabolism, nitrogen fixation, aerobic and anaerobic
respiration, enzymes of aromatic ring degradation and ex-
pression of virulence functions (1,2). Structural analysis has
led to the definition of the archetypical CRP fold which
is a versatile structure that has evolved so that members
of the super-family have differing functions in signal per-
ception, DNA-binding and interactions with RNA poly-
merase (3). Thus in different members of the family the sig-
nal molecules can be, for example, cyclic AMP (cAMP),
oxygen, carbon monoxide, nitric oxide or 2-oxoglutarate.
The best characterized member is CRP from the Gram-
negative bacterium Escherichia coli, which controls the ex-
pression of many genes in response to changes in the cellu-
lar concentration of cAMP (4). Thus, after cAMP binding
to the CRP dimer, the cAMP:CRP complex binds to pro-
moters containing DNA sequences similar to the consensus
sequence TGTGA(N6)TCACA (5). Subsequently CRP es-
tablishes specific protein:protein contacts with RNA poly-
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merase that promote transcription (6). Alternatively, CRP
represses transcription by promoter occlusion.
In Mycobacterium tuberculosis, a member of the
CRP/FNR superfamily, CRPMt (encoded by gene rv3676),
is a global transcription factor (7,8). Like the orthologous
protein in E. coli, CRPMt binds to cAMP, but in contrast
to the cAMP-dependent DNA-binding observed in E. coli,
the cAMP-CRPMt complex exhibits only a comparatively
small enhancement in DNA-binding (9). CRPMt regulates
gene expression positively and negatively and is required
for growth in vitro and in infections of macrophages and
mice (8).
CRPMt is not the only member of the CRP/FNR fam-
ily in M. tuberculosis; a second representative is coded by
the cmr (rv1675c) gene (10). This protein has been found
to be required for the expression of four genes previously
identified as cAMP-induced genes (10,11). For three of the
genes, rv1265, groEL2 andmdh, the Cmr protein was shown
to bind to the promoter region in electrophoretic mobility
shift assays (EMSAs), subsequently confirmed in the case
of groEL2 by further EMSA and in vitro transcription reac-
tions (10,12). Cmr was therefore identified as another mem-
ber of the CRP/FNR family that regulates cAMP-induced
genes and was accordingly given the abbreviation Cmr for
cAMP and macrophage regulator, since it was required for
the regulated expression of these genes during macrophage
infection (10). However, Cmr binding at the groEL2 pro-
moter was unaffected by cAMP and transcription in vitro
also was independent of cAMP (12).
Recently, Ranganathan et al. (13) reported the results
of a ChIP-seq (chromatin immunoprecipitation-DNA se-
quencing) analysis of the Cmr homologue inM. bovis BCG
Mb1702c (Cmr: 99% identical over 244 amino acids to M.
tuberculosis Cmr, Rv1675c), identifying the DNA sequence
recognized by Cmr and the distribution of binding sites
across the M. bovis BCG chromosome. In addition, ex-
posure of M. bovis BCG to the cAMP analogue (dibutyl-
cAMP) modulated Cmr binding at a subset of chromoso-
mal loci, including clusters of sites associated with mem-
bers of the DosR regulon that exhibited co-operative bind-
ing of Cmr (13,14). The DosR regulon is required for sur-
vival during anaerobic dormancy and thus is a critical com-
ponent of tuberculosis pathogenesis (14). Here, it is demon-
strated that DNA-binding by Cmr is not directly modulated
by cAMP but by oxidation/nitrosation of two conserved
cysteine residues and that the cmr mutant is resistant to
nitrosative stress. In addition, transcriptional profiling re-
vealed the influence of Cmr on DosR-regulated genes inM.
tuberculosis, suggesting a role for Cmr-mediated gene reg-
ulation in tuberculosis pathogenesis, which was supported
by transient attenuation of a cmrmutant in a mouse aerosol
infection model.
MATERIALS AND METHODS
Bacterial strains, plasmids and growth conditions
Mycobacterium tuberculosis, Mycobacterium smegmatis
and E. coli strains and plasmids are listed in Supplemen-
tary Table S1. Cultures ofM. tuberculosis (100ml) were typ-
ically grown in 1 l polycarbonate culture bottles (Techmate)
in a Bellco roll-in incubator (two revolutions per minute
(rpm)) at 37◦C in Dubos broth containing 0.05% (v/v)
Tween 80 supplemented with 0.2% (v/v) glycerol and 4%
Dubos medium albumin. Aerosol infections of mice were
carried out as described previously (15). Cultures of E. coli
and M. smegmatis mc2 155 (500 ml) were typically grown
in Lennox broth medium (16) in a 1:4 volume/flask ratio at
37◦C with shaking at 250 rpm.
Generation of an unmarked cmrM. tuberculosis deletion mu-
tant
Approximately 1 kb upstream and downstream of cmr
were amplified by PCR using oligonucleotides 1675c fwd1
(5′-CCGGTCGACCGCTGAGACTGGTTTATG-3′) and
1675c rev1 (5′-CAATGACACAGCGCCGGTCCCAC-
3′), and 1675c fwd2 (5′-TGCCATGGCCCCTCCTTG
AGAGC-3′) and 1675c rev2 (5′-CGGTCGACAAGTCG
TGCCCATCAAG-3′) (restriction enzyme sites used for
cloning are underlined), and fused in a consecutive PCR
using oligonucleotides 1675c fwd1 and 1675c rev2. The
resulting 2 kb product was cloned into vector p2NIL
creating plasmid p2NIL:1675c and verified by sequencing.
A PacI fragment from the vector pGOAL17 containing
PAg85-lacZ, Phsp60-sacB was ligated into the single PacI site
in p2NIL:1675c creating plasmid p2NIL:1675c.17.
Competent M. tuberculosis H37Rv cells were elec-
troporated with 1 g of plasmid p2NIL:1675c.17 and
transformants were selected on 7H11 medium plus
kanamycin (25 mg l−1) and 5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal; 40 mg l−1). Blue colonies
(single cross-overs) were re-streaked on 7H11-plates with-
out antibiotics to allow for recombination. A loopful
of cells was suspended and serial dilutions plated onto
7H11 + X-Gal + sucrose (2%). SucR (sucrose resistant)
colonies were then streaked onto plates with and without
kanamycin to identify KanS (kanamycin sensitive) colonies.
DNA from four potential cmr mutants was isolated using
Instagene matrix (BioRad) and subjected to PCR analysis.
One of the potential double crossovers was identified as a
mutant of cmr by PCR, and verified by DNA sequencing
over the cmr region. Genomes of the cmr mutant and wild
type M. tuberculosis were sequenced by GATC Biotech
using an Illumina MiSEq platform.
Construction of a cmr complementing plasmid
A cmr complementing construct with expression of
the gene under its own promoter was prepared by
PCR of genomic DNA using the following primers:
5′-GCGGTACCCTCGCGGTACTGCACTCGGT-3′
and 5′-GCGAATTCTCATTGAGCCCGGGCGCG-3′
(restriction enzyme sites underlined). The region amplified
contained the cmr gene and the region 500 bp upstream.
After digestion with KpnI and EcoRI this product was
cloned into the plasmid pKP186. This plasmid was verified
by DNA sequencing (GATC Biotech) and confirmed to
correspond to the base pairs 1900241–1901475 on the M.
tuberculosis H37Rv genome. The confirmed plasmid was
integrated into the chromosome using pBS-int as described
previously (8).
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cDNA labelling and transcriptomic analysis
Cultures ofM. tuberculosisH37Rv, the cmr deletion mutant
and a complemented mutant were grown aerobically in Du-
bosmedium supplementedwith 0.05%Tween 80, 0.2% glyc-
erol and 4% Dubos medium albumin to mid-exponential
phase (OD600 ∼0.6). RNA isolation from M. tuberculo-
sis liquid cultures was described previously (17). Whole
genome DNA microarrays of M. tuberculosis (version 2)
were provided by the BG@S group (St. George’s, Uni-
versity of London). cDNA labelling and RNA-DNA mi-
croarray hybridizations were described previously (8). Mi-
croarray slides were scanned as previously discussed (18)
and image quantitation performed using Bluefuse for Mi-
croarrays v3.6 (BlueGnome). Three biological replicates
were performed for each condition, carried out in dupli-
cate for dye-swaps. Thus, data were obtained from six slides,
including dye swaps, from three bacterial cultures. Data
were analysed using GeneSpring version 13 (Agilent), ap-
plying a global Lowess normalization to remove differences
in dye-incorporation efficiencies between microarrays. Fea-
tures with a Bluefuse confidence of <0.1 (a quality con-
trol metric utilized by the software to quantify spot quality)
were eliminated from further analysis. Genes were consid-
ered to be altered if they showed >3-fold change in abso-
lute expression and passed significance filtering by using a
t-test (P-value <0.1) applying a Benjamini and Hochberg
multiple testing correction. The array design is available in
ArrayExpress (accession numberA-BUGS-23). Fully anno-
tated microarray data have been deposited in ArrayExpress
(accession no. E-BUGS-155).
Overproduction and purification of Cmr
Cmr protein was overproduced with an N-terminal hexa-
His-tag in E. coli (BL21-DE3) from a pET28a derivative
pGS2103 (Supplementary Table S1). Cultures were grown
at 37◦C to an optical density (OD) of∼0.6, when IPTG (iso-
propyl -D-thiogalactoside; 120 g ml−1) was added and
the cultures incubated at 25◦C for a further 2 h. Cells were
lysed after resuspension in 20mM sodium phosphate buffer
(pH 7.4) containing 0.5 M NaCl by two passages through
a French pressure cell at 37 MPa. The cell-free extract (re-
sulting from centrifugation of the lysate) was applied to a 1
ml Hi-Trap Chelating column (GE Healthcare) and the re-
combinant Cmr isolated by elution with a linear imidazole
gradient (12).
Partial proteolysis
Trypsin digests of Cmr were optimized and the following
conditions used. Trypsin (Sigma) was used at a final con-
centration of 2.1 M in 10 mM Tris–HCl (pH 8.3), with
3.3 MCmr for 1 min at room temperature with and with-
out a 10-fold molar excess of cAMP (or other potential sig-
nal molecules). Reactions were stopped by the addition of
10% SDS and heated for 10 min at 100◦C before analysis
by sodium dodecylsulfate polyacrylamide gel electrophore-
sis (SDS-PAGE).
Electrophoretic mobility shift assays (EMSAs) and in vitro
transcription
EMSAs were performed using the cmr promoter (Pcmr)
region (unless stated otherwise). Pcmr was released from
pGS2462 (Supplementary Table S1) using EcoRI as a frag-
ment extending from –174 bp to +56 bp relative to the
start codon. The DNA fragment was end labelled using
0.37 MBq of [-32P]dCTP and Klenow enzyme (10 units)
for 60 min at room temperature. Unincorporated radionu-
cleotides were removed using a QIAquick PCR clean-up kit
(Qiagen). Increasing concentrations of recombinant Cmr
in the presence of 100 mM NaCl, 40 mM Tris–HCl (pH
8), 10 mM MgCl2, 1 mM ethylenediaminetetraacetic acid
(EDTA), 250 g ml−1 bovine serum albumin (BSA) and 1
g calf thymus DNA (300-fold excess) (12) were incubated
with different stress reagents as indicated (either DTT, 5
mM; diamide, 5 mM; or S-nitrosoglutathione (GSNO), 1
mM) for 30 min at room temperature. Radiolabelled DNA
(∼3 ng) was then added to the reactions and incubated
for 10 min at room temperature before the resulting com-
plexes were separated on 6% (w/v) polyacrylamide gels
buffered with Tris-glycine. Similar protocols were followed
for EMSAs with DNA fragments upstream of the groEL2,
rv2007c, rv2032, rv3133c and rv3134c genes released from
pCR4BLUNT-TOPOderivatives (Supplementary Table S1;
see Supplementary information for all DNA sequences used
in EMSAs).
Mycobacterium smegmatis RNA polymerase (RNAP)
holoenzyme was isolated from M. smegmatis mc2 155
as described (19). The rrnA and cmr promoter DNA
fragments were amplified from M. tuberculosis H37Rv
genomic DNA by PCR using primers rrnA F (5′-
TAGAGCAATTCGAACGGGTATGCTG-3′) and rrn R
(5′-TAGAGAATTGCTGTGAAACCACCAAACA-3′)
and primers cmr F (5′-TAGAGAATTCGTCCACCGG
TTG-3′) and cmr R (5′-TAGAGAATTCGAGCAGGCG
ATG-3′) respectively. Transcription was performed in 10
l transcription buffer (TB; 20 mM Tris–HCl, pH 8.0, 20
mM KCl, 10 mM MgCl2 and 5% (v/v) glycerol). Typically
a promoter fragment (20 nM) was incubated with Cmr at
the indicated concentrations for 10 min at 37◦C. RNAP
holoenzyme (200 nM) was added and the mixture was
incubated for 10 min at 37◦C. Transcription was initiated
by the addition of 250 M corresponding initiating NTPs,
10 M non-initiating NTPs and radiolabelled [-32P]
NTP as indicated. The reactions were stopped by adding
1 volume of stop buffer (1× TBE, 8 M urea). Products
were resolved by denaturing PAGE (8 M urea), visualized
by PhosphorImaging (GE Healthcare) and analyzed
using ImageQuant software (GE Healthcare). The DNA
sequences of the templates used in the in vitro transcription
reactions are provided in the Supplementary information.
Bio-layer interferometry (BLItz)
Pcmr was amplified from pGS2462 using a primer with a
5′-biotin label (Supplementary Table S1), and the resulting
DNA was extracted from a 1% (w/v) agarose gel using the
QIAquick gel extraction kit (Qiagen). The extracted DNA
was typically used at a concentration of 56 ngl−1 for bind-
ing to the streptavidin probe. Cmr (452 nM) was typically
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treated with a stress agent (as indicated) for ∼2 h before
binding to the probe. The association and dissociation rate
constants at 20◦C were calculated by curve fitting using the
BLItz software (ForteBio).
Mass spectrometry
Cmr samples (∼1 mg ml−1; ∼40 M) for liquid
chromatography–mass spectrometry (LC–MS) were
treated with appropriate stress agents (∼20 mM dithio-
threitol (DTT) or diamide) for 45 min on ice. Samples were
then diluted to (0.1 mg ml−1; ∼4 M) with an aqueous
mixture of 1% (v/v) acetonitrile, 0.3% (v/v) formic acid,
and loaded onto a ProSwift RP-1S column (4.6 × 50 mm)
(Thermo Scientific) on an Ultimate 2000 uHPLC system
(Dionex, Leeds, UK). Bound proteins were eluted (0.2 ml
min−1) using a linear gradient (15 min) from 1% to 100%
(v/v) acetonitrile, 0.1% (v/v) formic acid. The eluent was
continuously infused into a Bruker microQTOF-QIII mass
spectrometer, running Hystar (Bruker Daltonics, Coventry,
UK)), using positive mode electrospray ionization (ESI).
Compass Data Analysis, with Maximum Entropy v1.3,
(Bruker Daltonics, Coventry) was used for processing of
spectra under the LC peak. The mass spectrometer was
calibrated with ESI-L tuning mix (Agilent Technologies).
Alternatively, for LC-MS of Cmr before and after treatment
with 20-fold molar excess of GSNO for 1 h, samples were
diluted with Solvent A (water with 0.1% (v/v) formic acid)
and loaded onto an Agilent Zorbax Extended-C18 (2.1 ×
50 mm) column. Bound proteins were eluted (0.4 ml min−1)
using a gradient (10 min) of solvent B from 5% to 95% (v/v)
acetonitrile, 0.1% (v/v) formic acid. In this case, analysis
was carried out using an Agilent Technologies 6530 Q-ToF
LC–MS instrument, at The University of Sheffield Faculty
of Science Mass Spectrometry Centre.
Mycobacterium tuberculosis stress responses
Mycobacterium tuberculosis strains were grown in 7H9Mid-
dlebrook broth supplemented with 10% (v/v) albumin-
dextrose complex (ADC), 0.2% (v/v) glycerol and 0.05%
(w/v) Tween 80 at 37◦C with shaking (100 rpm) until
mid-exponential growth phase corresponding to OD580nm
∼0.5–0.6. The nitric oxide (NO) donor, 6-methoxy-5-
nitropyrimidin-4-yl pyrrolidine-1-carbodithioate (20), at a
final concentration of 100 Mwas used to assess the effect
of nitrosative stress onM. tuberculosis viability. For starva-
tion of M. tuberculosis, cultures were washed in phosphate
buffered saline (PBS) twice before being resuspended in
PBS. These cultureswere left static at 37◦C for up to 6weeks.
Mycobacterial viability following each of these stresses was
assessed by measuring the number of colony forming units
(cfus) after static incubation at 37◦C. Percentage survival
was calculated as the ratio of cfu after treatment to cfu be-
fore treatment multiplied by 100. Control chemicals which
do not release nitric oxide had no effect onmycobacterial vi-
ability. The minimum inhibitory concentrations (MICs) of
the NO donor were also assessed, using the micro-dilution
method. 7H9 Middlebrook broth supplemented with 10%
(v/v) albumin-dextrose complex, 0.2% (v/v) glycerol and
0.05% (w/v) Tween 80 containing 0.005% (w/v) of resazurin
supplemented with the NO donor (0-4 g ml−1 final con-
centration) was inoculated with M. tuberculosis bacilli (∼5
× 104). Growth of bacteria was monitored visually by the
change of blue colour to pink and turbidity. The first con-
centration that completely inhibited mycobacterial growth
was considered as the MIC.
Growth of M. tuberculosis in murine bone marrow-derived
macrophages
Growth of macrophages was carried out as described pre-
viously (15). Mycobacterium tuberculosis H37Rv, cmr mu-
tant and the complemented cmr mutant were grown in
7H9+ADCmedium (see above) to OD600 ∼0.4–0.8 in roller
bottles, centrifuged at 3000 rpm for 5 min, washed twice
with PBS + 0.05% (v/v) Tween 80 and centrifuged at 1200
rpm for 5 min to remove clumps. The concentration was
adjusted as required assuming OD600 of 1.0 is 5 × 107 cfu
ml−1, and dilutions were plated on agar to confirm exact
cfu. Macrophages (2 × 105) were infected at a moi (mul-
tiplicity of infection) of 1.0 for 4 h. Experiments were re-
peated three times.
Growth ofM. tuberculosis in mice
Mycobacterium tuberculosis cultures were grown in 7H9
medium to an OD600 of ∼0.6. Cultures were pelleted
and resuspended in Dulbecco’s modified Eagle’s medium
(DMEM, Sigma) plus 2 mM L-glutamine and 50% (v/v) fe-
tal calf serum to a concentration of 109 bacteria perml. Sub-
sequently, 10 ml bacterial stocks were prepared containing
∼105 cfu ml−1, and mice were infected with ∼100 cfu each,
using a Glas-Col aerosol infection system. Aerosol infec-
tions were performed at the National Institute for Medical
Research (Mill Hill, UK). The infection was monitored by
removing the lungs and spleens of infected mice at various
intervals, homogenizing the tissues, and plating 10-fold se-
rial dilutions on 7H11–OADC agar plates (Becton, Dick-
inson and Company) to determine the cfu values. The re-
sults for each time point are the means of cfu determina-
tions performed on organs fromfivemice, and the error bars
show the standard error of themean. Experiments involving
mice were conducted in strict accordance with the UK An-
imal (Scientific Procedures) Act 1986 under project license
80/2236 and all efforts were made to minimize suffering.
Female, specific pathogen free Balb/c mice (6–8 weeks old)
were obtained from the breeding facility at the National In-
stitute forMedical Research and the studies were performed
in containment category 3 animal facilities.
RESULTS AND DISCUSSION
DNA-binding and partial proteolysis of Cmr is unaffected by
cAMP
Mycobacterium tuberculosisH37Rv possesses two members
of the CRP family of transcription factors, Cmr (Rv1675c)
andRv3676 (21). Gel filtration analysis, and chemical cross-
linking both indicated that, like most other members of
the CRP/FNR superfamily, Cmr is dimeric (Supplemen-
tary Figure S1). Escherichia coli CRP and M. tuberculosis
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Figure 1. Cmr binding at the groEL2 promoter (PgroEL2) is independent
of cAMP and Cmr does not bind cAMP. (A) Radiolabelled PgroEL2 (am-
plified from p2126, Supplementary Table S1) was incubated with increas-
ing concentrations of Cmr, with or without cAMP (2 mM final concentra-
tion) as indicated, before separation of protein-DNAcomplexes (PgroEL2-
Cmr) from free DNA (PgroEL2) by electrophoresis. The final concentra-
tion of Cmr dimer in the assays is indicated above each lane. A diagram
(not to scale) showing features (arrow, transcript start; ATG, groEL2 trans-
lational start) of the DNA used in the EMSAs is shown below the autora-
diographs. (B) Partial proteolysis of Cmr in the presence and absence of a
10-fold molar excess of cAMP. Lane 1, Precision Plus Protein Standards
(BioRad) with molecular weights in kDa indicated; Lanes 2–6, reaction
components are as indicated below the image of the gel.
Rv3676 are global regulators that bind cAMP (22). How-
ever, Cmr lacks 15 of the 17 amino acids that form the
primary cAMP binding pocket of Rv3676 (23). The sec-
ondary cAMP-binding site in Rv3676 (composed of Asn67,
Asn137, Asp140 and Gln156) is also poorly conserved in
Cmr. Thus, although associated with regulation of cAMP-
and macrophage-induced genes, it was concluded that Cmr
was unlikely to interact with cAMP. Consistent with this
view Cmr binding to several potential target promoters was
unaffected by addition of cAMP (10,12). Here, Cmr binding
at the groEL2 promoter region was unaffected by addition
of 2 mM cAMP and partial proteolysis of Cmr in the pres-
ence and absence of cAMP (and other related nucleotides:
AMP,ADP,ATP, cCMP,CMP,CDP,CTP,UMP,UDPand
UTP) yielded identical profiles, indicating that Cmr does
not respond to cAMP or any of the other nucleotide lig-
ands tested (Figure 1). Thus, althoughM. bovis BCG Cmr
has been associated with cAMP-responsive gene regulation
in vivo (10), there is no evidence in favour of direct inter-
action between cAMP andM. tuberculosis Cmr (this work)
orM. bovis BCG Cmr (13, unpublished data). Other mem-
bers of the CRP family have been shown to utilize heme
and iron-sulfur clusters as sensory co-factors (2), but the
UV-visible spectrum of isolated Cmr did not indicate the
presence of these co-factors, nor did Cmr specifically incor-
porate heme or iron in reconstitution reactions. Thus, it was
concluded that Cmr does not bind cAMP and lacks cofac-
tors that could function as sensory modules.
Transcriptional profiling of cmr mutant
Comparison of the transcript profiles of aerobic mid-
exponential (OD600 ∼0.6) laboratory cultures of M. tuber-
culosis H37Rv and the cmr mutant showed that several
members of the DosR regulon were up-regulated compared
to the parental strain (Table 1). Thus, all the >3-fold up-
regulated genes in the cmrmutant were members of the Dos
regulon and the top the eight transcripts with the highest
induction ratios in the cmr mutant corresponded to those
most up-regulated under hypoxia, albeit in a different or-
der (Supplementary Table S2; 24). Transcript profiling of
the M. tuberculosis cmr mutant compared with the same
strain transformed with an integrated plasmid expressing
cmr resulted in extensive complementation of the mutant
transcription profile, indicating that the observed changes
in transcription were mediated by disruption of the cmr
gene (Table 1). Previous transcript profiling data obtained
by 6-fold over-expression of cmr suggested that no genes
were significantly regulated (≥2-fold, P ≤ 0.01) (25), hence,
the cmr mutant to parent comparison undertaken here has
revealed components of the Cmr regulon under laboratory
conditions for the first time. Although the changes in tran-
script abundance reported by Rustad et al. did not meet the
statistical criteria to be considered significant, nine Cmr-
repressed genes (rv0080, rv1738, rv2007c, rv2031c, rv2032,
rv2623, rv2626c, rv3130c, rv3131) detected here were also
repressed by Cmr when cmr was over-expressed (25).
Cmr is an auto-regulator and binds at the dosR promoter re-
gion
RNA-seq identified two weak transcript start sites (TSSs),
associated with plausible –10 elements, in the cmr gene (26).
The cmr TSSs are located 183 (TSS1) and 82 (TSS2) bp
upstream of the cmr start codon (Supplementary Figure
S2A). An inverted repeat (TGTCAGCGTGCTGACA) re-
lated to the Cmr consensus proposed by Ranganathan et al.
(13) was identified between the two cmr TSSs (Figure 2A).
Cmr binding at this location was shown by EMSAs (Fig-
ure 2B). Mutation of four bases in the palindromic regions
of the predicted binding site (TGTCAGCGTGCTGACA
to TATTAGCGTGCTAATA altered bases in bold) abol-
ished DNA-binding by Cmr (Figure 2C). This sequence-
specific binding was confirmed by competition experiments
in which a 5-fold excess of unlabelled cmr promoter DNA
(Pcmr) inhibited binding of Cmr to radiolabelled Pcmr (Fig-
ure 2D, compare lanes 2 and 3), whereas 5-fold unlabelled
Pcmr containing the mutated binding site did not (Figure
2D, compare lanes 2 and 4). In vitro transcription assays
confirmed that transcription of cmr is weak; end run-off
transcripts resulting from non-specific transcription initi-
ation from the ends of the linear 282 bp DNA fragment
containing the cmr-rv1676 intergenic region were relatively
strong and unaffected by the presence or absence of Cmr.
However, one specific transcript consistent with a size of 181
bases was produced in the presence of RNA polymerase,
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Table 1. Microarray data for theM. tuberculosis genes whose expression was altered >3-fold upon rv1675c deletion, compared to the wild-type







log2 ratio P value log2 ratio P value log2 ratio P value
Rv0079 rv0079 Unknown protein Yes 2.08 0.035 2.53 0.033 0.45 0.623
Rv0080 rv0080 Conserved hypothetical
protein
Yes 2.07 0.005 2.51 N/A 0.44 N/A
Rv1675c cmr Probable transcriptional
regulatory protein Cmr
–2.87 0.001 –1.85 0.203 1.02 0.013
Rv1737c narK2 Possible nitrate/nitrite
transported NarK2
Yes 1.58 0.038 2.01 0.077 0.42 0.582
Rv1738 rv1738 Conserved protein Yes 2.24 0.032 2.35 0.003 0.11 0.921
Rv2007c fdxA Ferredoxin FdxA Yes 3.09 0.023 2.72 0.000 –0.37 0.773
Rv2030c rv2030c Conserved protein Yes 3.05 0.015 2.88 0.009 –0.16 0.865
Rv2031c hspX Stress protein induced by
hypoxia
Yes 3 0.035 3.91 0.000 0.92 0.522
Rv2032 acg Conserved protein Acg Yes 1.88 0.031 2.29 0.019 0.41 0.657
Rv2623 TB31.7 Universal stress protein Yes 1.67 0.035 1.28 0.222 –0.39 0.564
Rv2626c hrp1 Hypoxic response protein 1
Hrp1
Yes 2.4 0.093 2.70 0.002 0.30 0.809
Rv2629 rv2629 conserved hypothetical
protein
Yes 2 0.018 1.00 0.227 –0.99 0.170
Rv3127 rv3127 conserved hypothetical
protein
Yes 1.64 0.074 2.04 0.025 0.39 0.696
Rv3130c tgs1 Triacylglycerol synthase
(diacylglycerol
acyltransferase) Tgs1
Yes 2.55 0.030 4.42 0.099 1.87 0.078
Rv3131 rv3131 Conserved protein Yes 2.63 0.040 3.00 0.002 0.37 0.764
Rv3133c dosR Two component
transcriptional regulatory
protein DosR
Yes 1.93 0.031 1.77 0.023 –0.16 0.872
Rv3134c rv3134c Universal stress protein
family protein
Yes 1.61 0.032 1.75 0.105 0.13 0.857
Values in bold and underlined indicate significance using a t-test (P value ≤ 0.1). N/A indicates insufficient data for significance testing.
and assigned as the cmr transcript originating from TSS1
(Figure 2A and E). Addition of Cmr protein resulted in
dose-dependent inhibition of transcription fromTSS1 while
the levels of two shorter transcripts increased; the first (con-
sistent with a size of 80 bases) was assigned as originating
from TSS2 and the second (consistent with a size of ≤80
bases) represented the divergent rv1676 transcript (Figure
2E, i; Supplementary Figure S2B). This suggests that Cmr
can recruit RNA polymerase to activate transcription from
divergent promoters as previously observed for the E. coli
CRP protein (27). These regulatory events were judged to
be specific because Cmr had relatively little effect on tran-
scription from the rrnA promoter 3 (Figure 2E, ii). Ad-
ditional evidence showing that Cmr acts independently of
cAMP was provided by Cmr-dependent transcription acti-
vation being unaltered in the presence or absence of cAMP
(Supplementary Figure S2C). Thus, like Cmr-mediated re-
pression (12), Cmr-dependent transcription activation was
cAMP-independent. Thus, it was concluded that Cmr binds
at the cmr-rv1676 intergenic region to repress the upstream
cmr promoter and activate both the downstream cmr pro-
moter and the divergent rv1676 promoter independently of
cAMP (Figure 2E, iii).
The DosS/T-DosR system responds to changes in re-
dox state, responding to hypoxia, nitric oxide and carbon
monoxide (28). Transcript profiling suggested that several
members of the Dos regulon (including dosR, rv3133c) were
regulated by Cmr (Table 1). It was reasoned that if Cmr was
a repressor of dosR transcription,mutation of cmrwould re-
lieve this repression and lead to the observed up-regulation
of DosR regulon genes. Therefore, four genes were selected
from amongst those exhibiting differential expression pat-
terns in the cmr mutant (Table 1) (rv2007c, rv2032, rv3133c
and rv3134c), and the DNA sequences upstream of the cod-
ing regions were used to test the hypothesis that Cmr ex-
erts control over the DosR regulon by regulation of dosR
expression. Whilst Cmr was unable to bind upstream of
rv2007c or rv2032, interaction was observed with DNA up-
stream of dosR (rv3133c) and rv3134c (Figure 3). The lat-
ter is co-transcribed as an rv3134c-dosR-dosS transcript
(29). Analysis of the DNA sequence upstream of rv3133c
and rv3134c revealed that both contained tandem sequences
similar to the Cmr binding site in Pcmr (cGTCAtCtggc-
cGcCA and gGTCAgCtgttcGtCg for rv3133c; and TGT-
CAtcggtcgataA and gGTCcccgccagtAac for rv3134c; con-
sensus bases in upper case), whereas rv2007c and rv2032
lacked such sequences (Figure 3E; Supplementary Figure
S3). The locations of the putative Cmr sites (–77, –16, +740
and +767 relative to the rv3134c transcript start) are consis-
tent with the proposal that Cmr represses expression of the
rv3134c-dosR-dosS operon.
Cmr is a redox sensor
The dysregulation of the DosR regulon in the cmr mutant
implicated Cmr in redox sensing. Further evidence link-
ing the Cmr to redox homeostasis is provided by the loca-
tion of the cmr gene itself. It is divergently transcribed from
rv1676 and dsbF (rv1677) and Cmr activates expression of
rv1676 in vitro (Figure 2E). DsbF is a thiol oxidase that is
required for the correct folding of surface- and secreted-
proteins that contain disulfide bonds (30). Rv1676 has a
peroxiredoxin-like 2 domain with potential role in anti-
oxidant defence under aerobic conditions (30). Accord-
ingly, rv1676 transcripts were detected in exponential aero-
bic cultures ofM. tuberculosis (SupplementaryFigure S2A).
Cmr has two cysteine residues (Cys36 and Cys131). Liquid
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Figure 2. Cmr binds to its own promoter in a site-specific manner to repress transcription. (A) DNA sequence covering the cmr-rv1676 intergenic region.
The locations of TSSs (bold upper case), potential –10 elements (underlined), the Cmr-binding site (bold lower case) and the cmr start codon (ATG) are
indicated. (B) Radiolabelled Pcmr was incubated with increasing concentrations of Cmr before separation of protein-DNA complexes (Pcmr-Cmr) from
free DNA (Pcmr) by electrophoresis. (C) Site-directed mutagenesis of the predicted Cmr binding site (GTCAGCGTGCTGCA to ATTAGCGTGCTAAT;
Pcmrmut) in Pcmr abolishes Cmr binding. For (B) and (C), the final concentrations of Cmr in the assays are indicated. (D) Competition assays in which
binding of Cmr (100 nM) to radiolabelled Pcmr (lane 2) was challenged by the presence of a 5-fold molar excess of unlabelled Pcmr (lane 3) or 5-fold molar
excess of unlabelled Pcmrmut (lane 4). A diagram (not to scale) showing features (arrows, transcript starts; ATG, cmr translational start) of the DNA locus
used in the EMSAs is shown below panel D. (E) In vitro transcription from the cmr-rv1676 intergenic region. (i) A 282 bp DNA fragment containing the
cmr-rv1676 intergenic region was incubated with M. smegmatis RNA polymerase along with the indicated concentrations of Cmr protein. Transcription
reactions were carried out as described in theMaterials and Methods. The locations of the cmr transcripts (TSS1, TSS2; Figure 2A), the rv1676 transcript
(rv1676) and the sizes of the calibrating RNA ladder (bases, b) are indicated. (ii) Control reactions were carried out using the rrnA promoter in the presence
of the indicated concentrations of Cmr. (iii) A schematic diagram of transcription regulation at the cmr-rv1676 intergenic region. Transcript starts (TSS,
arrows), transcripts (grey lines), transcript sizes and whether transcription is activated or repressed are indicated.
chromatography–mass spectrometry (LC–MS) showed that
reduced Cmr had the mass (30482.0 Da, including the His-
tag) predicted from the amino acid sequence (Figure 4A).
Treatment with diamide, which promotes disulfide bond
formation in susceptible proteins, gave a mass of 30480.5
Da, suggesting a loss of two protons, consistent with forma-
tion of an intramolecular disulfide bond betweenCys36 and
Cys131 (the only Cys residues in Cmr), suggesting the possi-
bility that Cmr acts as a redox sensor via a dithiol-disulfide
switch (Figure 4B).
The effect of the oxidation state of Cmr onDNA-binding
was assessed by EMSAs. Binding of reduced Cmr to Pcmr
was markedly enhanced compared to the oxidized pro-
tein (both diamide and H2O2-treated Cmr) (Figure 5A–C).
Bio-Layer Interferometry (BLItz) allowed the kinetics of
DNA-binding by Cmr to be measured in real time. Biotin-
labelled Pcmr was immobilized on streptavidin functional-
ized biosensor probes. Binding of Cmr to immobilized Pcmr
increases the thickness of the biological layer attached to
the optical surface of the probe. This change in thickness
creates an interference pattern in the reflected white light
emitted by the system, which is then detected by a spec-
trometer. These changes were fitted to a one-site binding
model to calculate rate constants for DNA-binding by Cmr.
This showed that the on-rate constant for reduced (di-thiol)
Cmr was ∼2-fold greater than that obtained for the oxi-
dized (disulfide) form of Cmr (Figure 5D; Table 2). Further-
more, the dissociation rate constant for oxidized Cmr was
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Figure 3. Cmr binds at the rv3134c-dosR-dosS region but not at all DosR-
regulated promoters. Radiolabelled DNA fragments amplified from the
regions upstream of (A) rv2007c, (B) rv2032, (C) rv3133c and (D) rv314c
were incubated with the indicated concentrations of Cmr before separation
of protein–DNA complexes from free DNA by electrophoresis. The loca-
tions of free DNA and Cmr complexes are indicated. Below each image
is a schematic representation (not to scale) of the DNA fragments used
in the EMSA (DNA sequences are provided in Supplementary informa-
tion). Numbering is relative to the locations of the transcript starts (+1, ar-
rows; 26). Start codons are also shown. (E) Schematic representation (not
to scale) of the rv3134c-dosR-dosS locus. The locations (relative to the ad-
jacent transcript starts) of DosR and predicted Cmr binding sites (boxes)
are shown. Bases that match the Cmr consensus in the predicted Cmr sites
are indicated in upper case.
∼6 times greater than that of reduced Cmr (Table 2). Thus,
the enhanced off-rate constant of oxidized Cmr is the ma-
jor determinant of the weaker binding of the disulfide form
of the protein (Figure 5D). These binding kinetics indicated
that the affinity of reduced Cmr for Pcmr (Kd = ∼2 × 10−8
M) was ∼10-fold greater than that for oxidized Cmr (Kd =
∼2 × 10−7 M) (Table 2). Replacement of one or both Cmr
Cys residues by Ala locked the protein in the ‘reduced’ state
resulting in enhanced DNA-binding under non-reducing
conditions compared to the wild-type Cmr (Supplementary
Figure S4). Thus, it was concluded that changes in the redox
Figure 4. Liquid Chromatography Mass Spectrometry analysis of Cmr.
Cmr analyzed in the (A) reduced (DTT-treated) and (B) oxidized (diamide-
treated) states.
state of Cmr induce conformational changes that modulate
its DNA-binding activity.
DNA-binding by Cmr is inhibited by nitrosation
The activities of transcription factors that possess reac-
tive thiols can be modulated by nitrosation (e.g. OxyR
in bacteria and Nuclear Factor B in eukaryotes; 31,32).
LC-MS of Cmr after exposure to the nitrosating agent S-
nitrosoglutathione (GSNO) showed peaks at 30482.5 Da
(unmodified Cmr; cf. Figure 6A), 30511.6Da (+29Da, Cmr
with oneNO adduct; reaction withNO results in loss of a H
atom fromCmr therefore net mass gain is 29Da rather than
the 30 Da mass of NO) and 30541.0 Da (+58.5 Da, Cmr
with two NO adducts) (Figure 6B). Nitrosation of Cmr in-
hibited binding at Pcmr in EMSAs (Figure 6C) and BLItz
assays indicated a∼30-fold decrease in the on-rate constant
for binding at Pcmr, without significantly altering the off-
rate constant (Figure 5D; Table 2).
Phenotypic characterization of the M. tuberculosis cmr mu-
tant
Modulation of the DNA-binding properties of Cmr by ni-
trosation suggested that it plays a role in the responses
to nitrosative stress. Therefore, the phenotypes of par-
ent, cmr mutant and the complemented mutant strains
upon exposure of cultures to the NO donor (6-methoxy-5-
nitropyrimidin-4-yl pyrrolidine-1-carbodithioate) were in-
vestigated. The viability of all three strains decreased after
24 h exposure, as judged by cfu measurements (Figure 7).
However, the cmr mutant survived significantly better than
the wild-type (P < 0.05, t-test), which in turn survived bet-
ter than the complemented mutant (Figure 7). Moreover,
determination ofMICs for the NO donor indicated that the
complementedmutant wasmore sensitive (0.2–0.4gml−1)
comparedwith the wild type and cmrmutant (1–2gml−1),
suggesting potential dysregulation of cmr in the comple-
mented mutant. The fact that the complemented cmr mu-
tant exhibited hyper-sensitivity to NO, suggested that pre-
cise control of cmr expression is critical for optimal func-
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Figure 5. DNA-binding by Cmr is affected by its redox state. Radiolabelled Pcmrwas incubated with the indicated concentrations of Cmr before separation
of protein–DNA complexes (Pcmr-Cmr) from free DNA (Pcmr) by electrophoresis. Reactions contained: (A) 5 mM DTT; (B) 5 mM diamide; (C) 5 mM
hydrogen peroxide (H2O2). A diagram (not to scale) showing features (arrows, transcript starts; ATG, cmr translational start) of the DNA locus used in
the EMSAs is shown below panel A. (D) BLItz assays. Biotin-labelled Pcmr bound to a streptavidin probe was exposed to reduced (blue line), oxidized
(red line) or nitrosated (green line) Cmr protein (452 nM).
Table 2. Rate constants for binding of reduced, oxidized and nitrosated Cmr at the cmr promoter
Sample ka (M−1 s−1)a kd (s−1)a Kd (M)a
Cmr reduced 1.4 × 105 ±5.4 × 102 2.8 × 10−3 ±1.9 × 10−5 1.9 × 10−8
Cmr oxidised 7.5 × 104 ±1.2 × 103 1.7 × 10−2 ±1.7 × 10−4 2.2 × 10−7
Cmr nitrosated 4.7 × 103 ±3.9 × 102 2.4 × 10−3 ±2.9 × 10−5 5.1 × 10−7
aValue and standard error for assays at 20◦C.
tion and that under- (mutant) or over- (complemented mu-
tant) expression of cmr results in dysregulation. This notion
was supported by qRT-PCR data showing that cmrwas∼2-
fold over-expressed in the complemented mutant and hence
there was a negative correlation between cmr expression and
sensitivity to nitrosative stress (Supplementary Figure S5).
The effect of the cmr deletion on the ability to survive un-
der starvation conditions was also investigated. However,
there was no significant difference in survival of the wild
type strain and the deletion mutant over a 6-week period.
Therefore Cmr does not appear to play a role in survival
during starvation. Similar survival patterns in response to
nitric oxide were previously observed in a pknH deletion
mutant ofM. tuberculosis indicating the complexity of reg-
ulatory pathways in this bacterium (33).
Mycobacterium tuberculosis cmr is implicated in virulence
The growth of the mutant in Dubos medium at 37◦C
(max = 0.063 h−1) and in mouse bone-marrow-derived
macrophages was indistinguishable from that of the wild-
type, in contrast to the crp (rv3676) mutant whose growth
was severely attenuated (8; Figure 8A). However, in aerosol
infected mice, there was a significant reduction in growth of
the cmr mutant in both lungs and spleen 30 days after in-
fection (Figure 8B and C). After 70 days, there was no dis-
cernible difference between the mutant and parent strains,
indicating that the cmr mutant is transiently attenuated in
the mouse model of infection. However, unlike the changes
in transcriptional regulation (Table 1), it was not possible
to complement the mutant phenotype using an integrating
plasmid-based system in this infection model (Figure 8B
and C). The possibility that the cmr deletion resulted in po-
lar effects on rv1674c-rv1672c was considered unlikely be-
cause the transcriptomic data indicated that expression of
these genes was unaltered in the cmr mutant strain. There-
fore, the genome sequences of the parent and cmr mutant
strains were obtained. Sequencing revealed the presence of
four gene deletions (rv0796, rv3184, rv3185 and rv3326) as-
sociated with transposases in both strains, as well as the
intended cmr deletion in the mutant strain. The rv0796,
rv3184 and rv3185 genes are deleted in some M. tubercu-
losis clinical isolates and therefore are unlikely to be neces-
sary for virulence (Supplementary Table S3). In addition to
these deletions, the cmr mutant had five single nucleotide
polymorphisms (SNPs) compared to the parent. Four of
these SNPs were unlikely to have any detrimental effect
on the mutant because the genes affected are not essential
for growth (fadE6: SNP, P7L; rv2323: SNP, L202P; rv3331:
SNP, P423T) or are found in other virulentM. tuberculosis
strains (prpD; SNP, R9P). Therefore, it was concluded that
individually none of these differences are likely to account
for the observed attenuation of the cmrmutant (further de-
tails are provided in Supplementary Table S2).However, it is
possible that, in combination, these genomic changes could
account for the inability to complement the cmr mutant in
the infection model; an alternative explanation is that the
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Figure 6. Cmr DNA-binding is inhibited by nitrosation. LC–MS of Cmr
before (A) and after (B) treatment with 20-foldmolar excess of GSNO for 1
h. (C) Radiolabelled Pcmrwas incubated with the indicated concentrations
of Cmr treated with 1mMGSNObefore separation of protein–DNA com-
plexes (Pcmr-Cmr) from free DNA (Pcmr) by electrophoresis. A schematic
representation (not to scale) the DNA locus used in the EMSA is shown
below the gel image; the location of the Cmr site (box) is indicated.
Figure 7. Phenotypes of the cmrmutant exposed to nitrosative stress. The
M. tuberculosis H37Rv cmr deletion mutant, wild-type and the comple-
mented mutant were incubated in the presence of 100 M NO donor 6-
methoxy-5-nitropyrimidin-4-yl pyrrolidine-1-carbodithioate for 24 h be-
fore assessment of survival by measurement of colony forming units (cfus).
The results of two independent experiments (filled and unfilled bars) are
shown. The error bars show the standard deviation from the mean (n= 3).
Significance was determined by the Student’s t test, ** P< 0.05 and * P<
0.1.
Figure 8. TheM. tuberculosis cmr deletionmutant is transiently attenuated
in a mouse aerosol infection model. (A) Growth of theM. tuberculosis cmr
mutant is unaffected in in vitro infections of mouse bone marrow-derived
macrophages. Survival and multiplication ofM. tuberculosis H37Rv (WT,
closed circles; solid line), the cmrmutant (closed inverted triangles; dashed
line) and the complemented mutant strain (closed squares; dashed line)
were assessed by measurement of colony forming units (cfus). The error
bars show the standard error of the mean (SEM) of three replicates. (B and
C) Survival and replication ofM. tuberculosisH37Rv (closed circles; solid
line), the cmr mutant (open circles; dashed line) and the complemented
mutant strain (closed inverted triangles; dashed line) in a mouse aerosol
infection model were assessed by measurement of bacterial load (cfu) in
the lungs (B) and spleen (C). In each case, one of two experiments is shown.
The results at each time point are the mean cfu values and the error bars
show the SEM (n = 4–5 mice per group). Significance was determined by
the Student’s t test. For lungs, day 30 cmrmutant vs. parent *** P< 0.001;
for spleen, day 30, cmr mutant versus parent * P < 0.05.
Nucleic Acids Research, 2017 11
amount of Cmr in the bacterium has to be tightly controlled
(see above). The latter explanation would be consistent with
the observed high-affinity binding of Cmr at Pcmr and con-
sequent auto-regulation and the fact that over-expression
of cmr from an hsp60 constitutive promoter resulted in in-
hibition of M. tuberculosis growth (Figure 2; Table 2; not
shown).
CONCLUDING REMARKS
Biochemical and molecular genetic analyses of the M.
tuberculosis transcription factor Cmr indicated that site-
specific binding to DNA sequences resembling the palin-
drome TGTCAGCGTGCTGACA (Figure 2) was severely
impaired upon exposure to nitrosative stress via nitrosation
of two cysteine residues (Figures 5 and 6). DNA-binding
by Cmr was also impaired, but less severely, when the same
cysteine residues were linked by formation of an intramolec-
ular disulfide bond, suggesting that nitrosative stress is the
major modulator of Cmr activity (Figures 4 and 5). Tran-
scriptional profiling and EMSAs indicated that Cmr re-
pressed major components of the DosR-regulon by bind-
ing at two promoters in the rv3134c-dosR-dosS operon (Ta-
ble 1; Figure 3). De-repression of the DosR-regulon in the
cmrmutant potentially prepares the bacterium for the chal-
lenges posed by nitrosative stress, providing a plausible ex-
planation for the observed enhanced resistance of the mu-
tant compared to the wild-type (Figure 7). It is notable
that the W/Beijing strains of M. tuberculosis, which are
attributed with properties of enhanced transmission, vir-
ulence and drug-resistance, constitutively over-express the
DosR-regulon in laboratory cultures (34). It is thought that
the up-regulation of the DosR-regulon prior to exposure to
inducing signals (usually associated with inhibition of respi-
ration and replication e.g. hypoxia and NO) pre-conditions
W/Beijing strains to survive the assaults of the host immune
system (35). This interpretation is consistent with the obser-
vation that the cmr mutant exhibits enhanced survival un-
der nitrosative stress conditions (Figure 7). Interestingly, the
rv1671 and rv1672c-1674c genes (Region of Difference 150)
that are located immediately adjacent to cmr were found to
be deleted in six strains of the East Asia clade of W/Beijing
strains (36). It is possible that these deletions modulate
the expression of cmr, thereby contributing to the over-
expression of the DosR-regulon. However, de-repression of
the DosR-regulon only partially accounts for the observa-
tions reported here. Whilst the ‘stress-ready’ state of theM.
tuberculosis cmrmutant provides a survival advantage when
challenged with nitric oxide donors in laboratory cultures
(Figure 7), it is neutral for survival in cultured macrophages
and results in transient attenuation in an aerosol model of
infection (Figure 8). This suggests that Cmr-mediated gene
regulation is complex and its influence overM. tuberculosis
stress responses extends beyond de-repression of the DosR-
regulon, as indicated by theChIP-seq data reported byRan-
ganathan et al. for M. bovis BCG (13). Moreover, Cmr-
mediated gene expression could be further complicated by
its capacity to respond to both oxidation and nitrosation.
Escherichia coli OxyR is a transcription factor that can
transduce different redox signals into bespoke transcrip-
tional responses via the altered DNA-binding affinities and
Figure 9. Working model for the role of Cmr in regulation of the Dos-
regulon in response to oxidative and nitrosative stresses. Under non-
stressed aerobic growth conditions Cmr exhibits high affinity site-specific
DNA-binding (Cmrred) and acts as a dual regulator of its own expression,
activates expression of the divergent rv1676 gene and represses expression
of DosR.Nitrosation (and to a lesser extent oxidation) of Cmr (Cmrox/NO)
results in de-repression of dosR, thereby activating expression of a subset
of the DosR-regulon (enclosed in ellipses).
cooperative behaviours of the oxidized and nitrosated forms
of the protein (31). The similarities in signal perception and
effects on DNA-binding affinity (high affinity binding for
reduced Cmr that was lowered for the disulfide form and
further impaired for the nitrosated form) suggest that Cmr
could be functionally equivalent to OxyR (Figure 9). Fur-
ther work to explore the breadth of theM. tuberculosisCmr
regulon should allow this suggestion to be tested.
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